Scoliosis-specific Exercises for Mild Idiopathic Scoliosis
Launched by KAROLINSKA INSTITUTET · Nov 17, 2021
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how specific exercises designed for scoliosis can help children with mild idiopathic scoliosis. Idiopathic scoliosis is a common condition where the spine curves abnormally, and it mainly affects children and teens. The researchers want to see if these exercises can prevent the condition from getting worse, especially in children who have a mild curve and are still growing.
To be eligible for the trial, participants should be between 9 and 15 years old, have a spinal curve measured between 15 and 24 degrees, and be in a stage of growth (meaning no signs of puberty for girls and certain skeletal maturity scores). The trial is currently looking for volunteers and is open to all genders. If your child qualifies and participates, they will be guided through a series of exercises specifically designed for their condition, and they will be monitored throughout the process. This trial aims to explore a potentially new approach to managing mild scoliosis without immediately resorting to braces or surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cobb 15-24 degrees
- • Skeletally immature, Sanders score of 4 or less and Risser \< 2.
- • No menarche for females
- • Aged 9-15 years
- • Apex of the primary curve at T7 or caudal
- Exclusion Criteria:
- • Non-idiopathic scoliosis (i.e. neuromuscular, syndromic or congenital scoliosis)
- • No previous surgical or brace treatment for scoliosis
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Linköping, , Sweden
Patients applied
Trial Officials
Elias Diarbakerli, PT, PhD
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials